SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-006201
Filing Date
2021-02-17
Accepted
2021-02-17 07:50:00
Documents
15
Period of Report
2021-02-10
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acor-8k_20210210.htm   iXBRL 8-K 43901
2 EX-99.1 acor-ex991_29.htm EX-99.1 10211
3 EX-99.2 acor-ex992_55.htm EX-99.2 517332
4 GRAPHIC gsio51512ziv000001.jpg GRAPHIC 15708
  Complete submission text file 0001564590-21-006201.txt   742145

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA acor-20210210.xsd EX-101.SCH 5768
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20210210_lab.xml EX-101.LAB 18732
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20210210_pre.xml EX-101.PRE 11167
8 EXTRACTED XBRL INSTANCE DOCUMENT acor-8k_20210210_htm.xml XML 3419
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 21642667
SIC: 2836 Biological Products, (No Diagnostic Substances)